Name: 14th Summit OnBiosimilars & Innovator Biologics
Start: 2023-06-27
End: 2023-06-28

14th Summit On Biosimilars & Innovator Biologics

27
Jun

28
Jun

2023

When

Boston

USA

Where

2023 will be a critical year for the success of biosimilar uptake and patient access.
Biosimilar launches are growing at a steady pace — but they are still not readily prescribed.
Despite the number of product launches, biosimilar adoption in the U.S. has been deficient, especially compared to Europe. Since 2007, 30 biosimilars for 12 large molecules have launched in the U.S. 10 more biosimilars have been approved and are set to launch by the end of 2023, and more significant launches are expected in the next five years.

Why Attend

14th Summit On Biosimilars & Innovator Biologics

Discuss the emerging trends and developments in the biosimilars marketplace.

Grow

Gain a deeper understanding of key litigations and decisions, biosimilar carve-outs, biologics ethics module, biologic patent portfolio strategies and more.

Experience

Explore interactive sessions and discussions led by industry experts to understand the impact on biologic innovation and the biosimilar marketplace.

Be inspired

Be inspired by top industry leaders to discover innovative approaches, uncover new business opportunities, and drive positive change in the Biosimilar industry.

Similar Events

American Conference Institute

0/5

(0)

For nearly 40 years, C5 Group companies including American Conference Institute, The Canadian Institute, C5 (UK), have developed and hosted conferences, summits and executive briefings providing the business intelligence that decision makers need to react decisively and effectively to challenges and opportunities in the marketplace.

27 - 28 Jun 2023

Hybrid

Speakers and Delegates
Industry Experts and Thought Leaders

Henry Gu

SVP, Head of Intellectual Property

Zentalis Pharmaceuticals

James Evans

Senior Director, Assistant General Counsel, Dispute Resolution

Regeneron

Cory Wohlbach

Global Vice President, Biosimilar Regulatory Affairs

Teva Pharmaceuticals

Anu Sawkar

Special Counsel for Intellectual Property

Federal Trade Commission

Mustafa Unlu

Software Engineering Manager

Delivery Hero

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Venable LLP

More than a law firm, Venable LLP is a network of trusted advisors serving businesses, organizations, and individuals in many of the most important aspects of their work.

Venable LLP

More than a law firm, Venable LLP is a network of trusted advisors serving businesses, organizations, and individuals in many of the most important aspects of their work.

Akin Gump Strauss Hauer & Feld LLP

Akin Gump is a global law firm with more than 900 lawyers and advisors who pride themselves on dedication to their clients and their communities.

Akin Gump Strauss Hauer & Feld LLP

Akin Gump is a global law firm with more than 900 lawyers and advisors who pride themselves on dedication to their clients and their communities.

Steptoe and Johnson PLLC

In more than 100 years of practice, Steptoe has earned an international reputation for vigorous representation of clients before governmental agencies, successful advocacy in litigation and arbitration, and creative and practical advice in structurin

Steptoe and Johnson PLLC

Axinn, Veltrop & Harkrider LLP

A firm to turn to when all seems hopeless -Chambers USA Axinn combines the skills, experience and dedication of the world's largest firms with the focus, responsiveness, efficiency and attention to client needs of the best boutiques.

Axinn, Veltrop & Harkrider LLP

Kramer Levin Naftalis & Frankel LLP

Kramer Levin provides its clients proactive, creative and pragmatic solutions that address today’s most challenging legal issues.

Kramer Levin Naftalis & Frankel LLP

Kramer Levin provides its clients proactive, creative and pragmatic solutions that address today’s most challenging legal issues.

Why Attend

14th Summit On Biosimilars & Innovator Biologics